I. Spiers

发表

Biodegradable Microparticles with Different Release Profiles: Effect on the Immune Response After a Single Administration via Intranasal and Intramuscular Routes

L. Baillie, J. Eyles, E. Williamson, 2000, The Journal of pharmacy and pharmacology.

Inositol polyphosphate‐mediated iron transport in Pseudomonas aeruginosa

A. M. Riley, B. Potter, D. Poyner, 1999, Journal of applied microbiology.

Synthesis and iron binding studies of myo-inositol 1,2,3-trisphosphate and (+/-)-myo-inositol 1,2-bisphosphate, and iron binding studies of all myo-inositol tetrakisphosphates.

Y. Chang, J. Gardiner, D. Poyner, 1996, Carbohydrate research.

Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines.

J. Eyles, E. Williamson, I. Spiers, 1998, Vaccine.

The conformation of an inhibitor bound to the gastric proton pump

David G. Reid, D. Middleton, A. Watts, 1997, FEBS letters.

Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse.

J. Eyles, E. Williamson, I. Spiers, 1998, Vaccine.

Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.

J. Bruin, M. Shahid, G. Dent, 1995, The Journal of pharmacology and experimental therapeutics.

Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy.

J. Eyles, E. Williamson, I. Spiers, 2000, Vaccine.

Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6.

H. Alpár, J. Eyles, E. Williamson, 2002, Vaccine.

Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits.

J. Eyles, E. Williamson, S. M. Jones, 2000, Journal of controlled release : official journal of the Controlled Release Society.

Structure of (+/-)-1,2;4,5-di-O-cyclohexylidene myo-inositol and synthesis of myo-inositol 3-phosphate via its phosphorylation with (2R,4S,5R)-2-chloro-3,4-dimethyl-5-phenyl-1,3,2-oxazaphospholidin-2-one

A. J. Blake, A. Blake, S. Freeman, 1997 .

The first synthesis and iron binding studies of the natural product, myo-inositol 1,2,3-trisphosphate

D. Poyner, S. Freeman, I. Spiers, 1995 .

Tissue distribution of radioactivity following intranasal administration of radioactive microspheres

J. Eyles, E. Williamson, I. Spiers, 2001, The Journal of pharmacy and pharmacology.

Direct synthesis, substitution, and structure of 1-(2′-deoxyβ-D-erythro-pentofuranosyl)-4-pentafluorophenylpyrimidin-2H-one

I. Spiers, W. Fraser, C. Schwalbe, 1995 .

Crystal structure and modelling studies of myo-inositol 1,2,3-trisphosphate

S. Freeman, I. Spiers, C. Schwalbe, 1995 .

Studies on the Co‐encapsulation, Release and Integrity of Two Subunit Antigens: rV and rF1 from Yersinia pestis

A. Bozkır, J. Eyles, E. Williamson, 1999, The Journal of pharmacy and pharmacology.